dc.contributor.author | Murray, J | |
dc.contributor.author | Cruickshank, C | |
dc.contributor.author | Bird, T | |
dc.contributor.author | Bell, P | |
dc.contributor.author | Braun, J | |
dc.contributor.author | Chuter, D | |
dc.contributor.author | Ferreira, MR | |
dc.contributor.author | Griffin, C | |
dc.contributor.author | Hassan, S | |
dc.contributor.author | Hujairi, N | |
dc.contributor.author | Melcher, A | |
dc.contributor.author | Miles, E | |
dc.contributor.author | Naismith, O | |
dc.contributor.author | Panades, M | |
dc.contributor.author | Philipps, L | |
dc.contributor.author | Reid, A | |
dc.contributor.author | Rekowski, J | |
dc.contributor.author | Sankey, P | |
dc.contributor.author | Staffurth, J | |
dc.contributor.author | Syndikus, I | |
dc.contributor.author | Tree, A | |
dc.contributor.author | Wilkins, A | |
dc.contributor.author | Hall, E | |
dc.contributor.author | PEARLS Trial Management Group, | |
dc.coverage.spatial | Ireland | |
dc.date.accessioned | 2022-11-25T09:47:52Z | |
dc.date.available | 2022-11-25T09:47:52Z | |
dc.date.issued | 2022-11-01 | |
dc.identifier | S2405-6308(22)00078-7 | |
dc.identifier.citation | Clinical and Translational Radiation Oncology, 2022, 37 pp. 130 - 136 | |
dc.identifier.issn | 2405-6308 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/5576 | |
dc.identifier.eissn | 2405-6308 | |
dc.identifier.eissn | 2405-6308 | |
dc.identifier.doi | 10.1016/j.ctro.2022.09.003 | |
dc.description.abstract | PEARLS is a multi-stage randomised controlled trial for prostate cancer patients with pelvic and/or para-aortic PSMA-avid lymph node disease at presentation. The aim of the trial is to determine whether extending the radiotherapy field to cover the para-aortic lymph nodes (up to L1/L2 vertebral interspace) can improve outcomes for this patient group. | |
dc.format | Electronic-eCollection | |
dc.format.extent | 130 - 136 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER IRELAND LTD | |
dc.relation.ispartof | Clinical and Translational Radiation Oncology | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | IMRT | |
dc.subject | PSMA-PET | |
dc.subject | Para-aortic lymph nodes | |
dc.subject | Prostate | |
dc.subject | Randomized controlled trial | |
dc.title | PEARLS - A multicentre phase II/III trial of extended field radiotherapy for androgen sensitive prostate cancer patients with PSMA-avid pelvic and/or para-aortic lymph nodes at presentation. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2022-09-18 | |
dc.date.updated | 2022-11-24T14:40:38Z | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1016/j.ctro.2022.09.003 | |
rioxxterms.licenseref.startdate | 2022-11-01 | |
rioxxterms.type | Journal Article/Review | |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/36238579 | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Closed research teams/Clinical Academic Radiotherapy (Dearnaley) | |
pubs.organisational-group | /ICR/Students | |
pubs.organisational-group | /ICR/Students/PhD and MPhil | |
pubs.organisational-group | /ICR/Students/PhD and MPhil/19/20 Starting Cohort | |
pubs.organisational-group | /ICR/ImmNet | |
pubs.organisational-group | /ICR/Students/PhD and MPhil/13/14 Starting Cohort | |
pubs.publication-status | Published online | |
pubs.publisher-url | http://dx.doi.org/10.1016/j.ctro.2022.09.003 | |
pubs.volume | 37 | |
icr.researchteam | Clinic Acad RT Dearnaley | |
icr.researchteam | Clin Trials & Stats Unit | |
icr.researchteam | Targeted Therapy | |
dc.contributor.icrauthor | Murray, Julia | |
dc.contributor.icrauthor | Cruickshank, Clare | |
dc.contributor.icrauthor | Griffin, Clare | |
dc.contributor.icrauthor | Melcher, Alan | |
dc.contributor.icrauthor | Philipps, Lara | |
dc.contributor.icrauthor | Corbett, Anna | |
dc.contributor.icrauthor | Hall, Emma | |
icr.provenance | Deposited by Mrs Jessica Perry (impersonating Prof Emma Hall) on 2022-11-24. Deposit type is initial. No. of files: 1. Files: PEARLS - A multicentre phase IIIII trial of extended field radiotherapy for androgen sensitive prostate cancer patients with.pdf | |